# Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

> **NCT01363466** · PHASE3 · TERMINATED · sponsor: **UNICANCER** · enrollment: 61 (actual)

## Conditions studied

- Stage IB2 Cervical Cancer
- Stage II Cervical Cancer
- Adenocarcinoma
- Squamous Cell Carcinoma
- Adenosquamous Carcinoma

## Interventions

- **PROCEDURE:** hysterectomy

## Key facts

- **NCT ID:** NCT01363466
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 61 (ACTUAL)
- **Why stopped:** low recruitment
- **Last updated:** 2011-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01363466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01363466, "Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01363466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*